{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T03:30:58Z","timestamp":1781148658220,"version":"3.54.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,2,9]],"date-time":"2017-02-09T00:00:00Z","timestamp":1486598400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Toxicol"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s12012-017-9403-5","type":"journal-article","created":{"date-parts":[[2017,2,9]],"date-time":"2017-02-09T11:20:48Z","timestamp":1486639248000},"page":"451-457","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Severe Proarrhythmic Potential of the Antiemetic Agents Ondansetron and Domperidone"],"prefix":"10.1007","volume":"17","author":[{"given":"Gerrit","family":"Frommeyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Ellermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp S.","family":"Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk G.","family":"Dechering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Kochh\u00e4user","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Fehr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Eckardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,9]]},"reference":[{"key":"9403_CR1","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1097\/00000542-200506000-00006","volume":"102","author":"B Charbit","year":"2005","unstructured":"Charbit, B., Albaladejo, P., Funck-Brentano, C., Legrand, M., Samain, E., & Marty, J. (2005). Prolongation of QTc interval after postoperative nausea and vomiting treatment by droperidol or ondansetron. Anesthesiology, 102, 1094\u20131100.","journal-title":"Anesthesiology"},{"key":"9403_CR2","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.curtheres.2005.10.003","volume":"66","author":"FM Schnell","year":"2005","unstructured":"Schnell, F. M., & Coop, A. J. (2005). An evaluation of potential signals for ventricular arrhythmia and cardiac arrest with dolasetron, ondansetron, and granisetron in the FDA combined spontaneous reporting system\/adverse event reporting system. Current Therapeutic Research, Clinical and Experimental, 66, 409\u2013419.","journal-title":"Current Therapeutic Research, Clinical and Experimental"},{"key":"9403_CR3","first-page":"53","volume":"3","author":"MJ Hafermann","year":"2011","unstructured":"Hafermann, M. J., Namdar, R., Seibold, G. E., & Page, R. L. (2011). Effect of intravenous ondansetron on QT interval prolongation in patients with cardiovascular disease and additional risk factors for torsades: A prospective, observational study. Drug, Healthcare and Patient Safety, 3, 53\u201358.","journal-title":"Drug, Healthcare and Patient Safety"},{"key":"9403_CR4","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s12630-010-9288-2","volume":"57","author":"K McKechnie","year":"2010","unstructured":"McKechnie, K., & Froese, A. (2010). Ventricular tachycardia after ondansetron administration in a child with undiagnosed long QT syndrome. Canadian Journal of Anaesthesia, 57, 453\u2013457.","journal-title":"Canadian Journal of Anaesthesia"},{"key":"9403_CR5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000083234","volume":"74","author":"S Claassen","year":"2005","unstructured":"Claassen, S., & Zunkler, B. J. (2005). Comparison of the effects of metoclopramide and domperidone on HERG channels. Pharmacology, 74, 31\u201336.","journal-title":"Pharmacology"},{"key":"9403_CR6","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1007\/s00246-004-0922-z","volume":"26","author":"CM Rocha","year":"2005","unstructured":"Rocha, C. M., & Barbosa, M. M. (2005). QT interval prolongation associated with the oral use of domperidone in an infant. Pediatric Cardiology, 26, 720\u2013723.","journal-title":"Pediatric Cardiology"},{"key":"9403_CR7","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1365-2125.2011.04093.x","volume":"73","author":"MJ Boyce","year":"2012","unstructured":"Boyce, M. J., Baisley, K. J., & Warrington, S. J. (2012). Pharmacokinetic interaction between domperidone and ketoconazole leads to QT prolongation in healthy volunteers: A randomized, placebo-controlled, double-blind, crossover study. British Journal of Clinical Pharmacology, 73, 411\u2013421.","journal-title":"British Journal of Clinical Pharmacology"},{"key":"9403_CR8","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1517\/14740338.2014.851193","volume":"13","author":"SA Doggrell","year":"2014","unstructured":"Doggrell, S. A., & Hancox, J. C. (2014). Cardiac safety concerns for domperidone, an antiemetic and prokinetic, and galactogogue medicine. Expert Opinion on Drug Safety, 13, 131\u2013138.","journal-title":"Expert Opinion on Drug Safety"},{"key":"9403_CR9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/cpdd.126","volume":"4","author":"J Biewenga","year":"2015","unstructured":"Biewenga, J., Keung, C., Solanki, B., Natarajan, J., Leitz, G., Deleu, S., et al. (2015). Absence of QTc prolongation with domperidone: A randomized, double-blind, placebo- and positive-controlled thorough QT\/QTc study in healthy volunteers. Clinical Pharmacology in Drug Development, 4, 41\u201348.","journal-title":"Clinical Pharmacology in Drug Development"},{"key":"9403_CR10","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1093\/eurjhf\/hfr107","volume":"13","author":"G Frommeyer","year":"2011","unstructured":"Frommeyer, G., Milberg, P., Witte, P., Stypmann, J., Koopmann, M., Lucke, M., et al. (2011). A new mechanism preventing proarrhythmia in chronic heart failure: Rapid phase-III repolarization explains the low proarrhythmic potential of amiodarone in contrast to sotalol in a model of pacing-induced heart failure. European Journal of Heart Failure, 13, 1060\u20131069.","journal-title":"European Journal of Heart Failure"},{"key":"9403_CR11","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ejphar.2016.02.051","volume":"776","author":"G Frommeyer","year":"2016","unstructured":"Frommeyer, G., Fischer, C., Lange, P. S., Leitz, P., Fehr, M., Bogossian, H., et al. (2016). Divergent electrophysiologic profile of fluconazole and voriconazole in an experimental whole-heart model of proarrhythmia. European Journal of Pharmacology, 776, 185\u2013190.","journal-title":"European Journal of Pharmacology"},{"key":"9403_CR12","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ejphar.2016.06.029","volume":"788","author":"G Frommeyer","year":"2016","unstructured":"Frommeyer, G., Brucher, B., Von der Ahe, H., Kaese, S., Dechering, D. G., Kochhauser, S., et al. (2016). Low proarrhythmic potential of citalopram and escitalopram in contrast to haloperidol in an experimental whole-heart model. European Journal of Pharmacology, 788, 192\u2013199.","journal-title":"European Journal of Pharmacology"},{"key":"9403_CR13","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1124\/jpet.102.037911","volume":"303","author":"P Milberg","year":"2002","unstructured":"Milberg, P., Eckardt, L., Bruns, H. J., Biertz, J., Ramtin, S., Reinsch, N., et al. (2002). Divergent proarrhythmic potential of macrolide antibiotics despite similar QT prolongation: Fast phase 3 repolarization prevents early afterdepolarizations and torsade de pointes. Journal of Pharmacology and Experimental Therapeutics, 303, 218\u2013225.","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"9403_CR14","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1124\/jpet.300.1.64","volume":"300","author":"L Eckardt","year":"2002","unstructured":"Eckardt, L., Breithardt, G., & Haverkamp, W. (2002). Electrophysiologic characterization of the antipsychotic drug sertindole in a rabbit heart model of torsade de pointes: Low torsadogenic potential despite QT prolongation. Journal of Pharmacology and Experimental Therapeutics, 300, 64\u201371.","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"9403_CR15","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/j.1540-8159.1998.tb00148.x","volume":"21","author":"DM Roden","year":"1998","unstructured":"Roden, D. M. (1998). Taking the \u201cidio\u201d out of \u201cidiosyncratic\u201d: Predicting torsades de pointes. Pacing and Clinical Electrophysiology: PACE, 21, 1029\u20131034.","journal-title":"Pacing and Clinical Electrophysiology: PACE"},{"key":"9403_CR16","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1161\/01.CIR.81.2.686","volume":"81","author":"LM Hondeghem","year":"1990","unstructured":"Hondeghem, L. M., & Snyders, D. J. (1990). Class III antiarrhythmic agents have a lot of potential but a long way to go. Reduced effectiveness and dangers of reverse use dependence. Circulation, 81, 686\u2013690.","journal-title":"Circulation"},{"key":"9403_CR17","first-page":"100","volume":"15","author":"C Antzelevitch","year":"2008","unstructured":"Antzelevitch, C. (2008). Drug-induced spatial dispersion of repolarization. Cardiology Journal, 15, 100\u2013121.","journal-title":"Cardiology Journal"},{"key":"9403_CR18","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0735-1097(97)00333-1","volume":"30","author":"SC Verduyn","year":"1997","unstructured":"Verduyn, S. C., Vos, M. A., Van der Zande, J., Kulcsar, A., & Wellens, H. J. (1997). Further observations to elucidate the role of interventricular dispersion of repolarization and early afterdepolarizations in the genesis of acquired torsade de pointes arrhythmias: A comparison between almokalant and d-sotalol using the dog as its own control. Journal of the American College of Cardiology, 30, 1575\u20131584.","journal-title":"Journal of the American College of Cardiology"},{"key":"9403_CR19","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0008-6363(98)00043-1","volume":"39","author":"L Eckardt","year":"1998","unstructured":"Eckardt, L., Haverkamp, W., Borggrefe, M., & Breithardt, G. (1998). Experimental models of torsade de pointes. Cardiovascular Research, 39, 178\u2013193.","journal-title":"Cardiovascular Research"},{"key":"9403_CR20","first-page":"424","volume":"3","author":"I Sardi","year":"2013","unstructured":"Sardi, I., La Marca, G., Cardellicchio, S., Giunti, L., Malvagia, S., Genitori, L., et al. (2013). Pharmacological modulation of blood-brain barrier increases permeability of doxorubicin into the rat brain. American Journal of Cancer Research, 3, 424\u2013432.","journal-title":"American Journal of Cancer Research"},{"key":"9403_CR21","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1161\/01.CIR.102.16.1883","volume":"102","author":"B Drolet","year":"2000","unstructured":"Drolet, B., Rousseau, G., Daleau, P., Cardinal, R., & Turgeon, J. (2000). Domperidone should not be considered a no-risk alternative to cisapride in the treatment of gastrointestinal motility disorders. Circulation, 102, 1883\u20131885.","journal-title":"Circulation"}],"container-title":["Cardiovascular Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12012-017-9403-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-017-9403-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-017-9403-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,9,18]],"date-time":"2017-09-18T08:44:39Z","timestamp":1505724279000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12012-017-9403-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,9]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["9403"],"URL":"https:\/\/doi.org\/10.1007\/s12012-017-9403-5","relation":{},"ISSN":["1530-7905","1559-0259"],"issn-type":[{"value":"1530-7905","type":"print"},{"value":"1559-0259","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,9]]}}}